Forex
World
Market
Business
Cryptocurrency
Commodities
MAP
Publish for free
Business
financetom
/
Business
/
--Merck Discontinuing Phase 3 Trials of Keytruda in Non-Small Cell Lung Cancer, Skin Cancer
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
Forex
Stocks Market
Commodities
--Merck Discontinuing Phase 3 Trials of Keytruda in Non-Small Cell Lung Cancer, Skin Cancer
Aug 29, 2024 4:07 AM
06:40 AM EDT, 08/29/2024 (MT Newswires) --
Price: 117.00, Change: -0.40, Percent Change: -0.34
Previous page:
France's election stokes far-right linked violence
Next page:
Rocket Pharmaceuticals Says FDA Seeks More Information on Kresladi
Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Release time ⇩
Release time ⇧
Like count ⇩
Show More Comments
Related Articles >
France's election stokes far-right linked violence
Jun 28, 2024
(Note offensive language in paragraph 19) * Rights groups say far-right sympathisers emboldened * RN says no link to neo-Nazi groups, violence is red line * Ministers warn of threats to civil order By Juliette Jabkhiro and Layli Foroudi PARIS, June 28 (Reuters) - When a Green party activist was headbutted in the street, his attackers told him there was...
Rocket Pharmaceuticals Says FDA Seeks More Information on Kresladi
Jun 28, 2024
10:28 AM EDT, 06/28/2024 (MT Newswires) -- Rocket Pharmaceuticals ( RCKT ) said Friday that the US Food and Drug Administration has issued a Complete Response Letter following its Biologics License Application for Kresladi to treat severe leukocyte adhesion deficiency-I. The company said the FDA requested limited additional Chemistry Manufacturing and Controls information to complete its review. Rocket said it...
European Commission To Decide On Hewlett Packard Enterprise's $14B Juniper Networks Acquisition By August 1: Details
Jun 28, 2024
The European Commission regulators are reportedly set to decide by August 1 on whether to approve Hewlett Packard Enterprise Company’s $14 billion acquisition of Juniper Networks, Inc. ( JNPR ) . Announced in January, the deal aims to enhance Hewlett Packard Enterprise’s artificial intelligence offerings and expand its networking business, reflecting the strategic focus on AI as a key growth...
Citigroup urges dismissal of ex-managing director's whistleblower lawsuit
Jun 28, 2024
NEW YORK (Reuters) -Citigroup urged a judge to dismiss a lawsuit by a former managing director who accused the bank of firing her in retaliation for refusing to give regulators false information. The third-largest U.S. bank said it lawfully terminated Kathleen Martin because she lacked the leadership and engagement skills needed for her job as interim data transformation chair, according...
About
Terms and Conditions
Privacy policy
Cookie Settings
Contact Us
Services
Login
register
financetom
Market
Personal Finance
Business
Economy
Cryptocurrency
MAP
Links
zpostcode
Recruit
weather
mreligion
Yellowpages
sport
constellation
shopping
name
game
directory
literature
Word
tour
furnish
Lottery
tftnews
lyrics
News
digital
car
dir
Edu
Finance
Copyright 2023-2026 -
www.financetom.com
All Rights Reserved
News
World
Market
Environment
Technology
Personal Finance
Politics
Retail
Business
Economy
Cryptocurrency
MAP